Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:2016:9434250.
doi: 10.1155/2016/9434250. Epub 2016 Sep 21.

Modulation of Immunoregulatory Properties of Mesenchymal Stromal Cells by Toll-Like Receptors: Potential Applications on GVHD

Affiliations
Review

Modulation of Immunoregulatory Properties of Mesenchymal Stromal Cells by Toll-Like Receptors: Potential Applications on GVHD

Bruno Sangiorgi et al. Stem Cells Int. 2016.

Abstract

In the last decade, the immunomodulatory properties of mesenchymal stromal cells (MSCs) have attracted a lot of attention, due to their potential applicability in the treatment of graft-versus-host disease (GVHD), a condition frequently associated with opportunistic infections. The present review addresses how Pathogen-Associated Molecular Patterns (PAMPS) modulate the immunosuppressive phenotype of human MSCs by signaling through Toll-like receptors (TLRs). Overall, we observed that regardless of the source tissue, human MSCs express TLR2, TLR3, TLR4, and TLR9. Stimulation of distinct TLRs on MSCs elicits distinct inflammatory signaling pathways, differentially influencing the expression of inflammatory factors and the ability of MSCs to suppress the proliferation of immune system cells. The capacity to enhance the immunosuppressive phenotype of MSCs through TLRs stimulation might be properly elucidated in order to improve the MSC-based immunotherapy against GVHD.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Friedenstein A. J., Piatetzky S., II, Petrakova K. V. Osteogenesis in transplants of bone marrow cells. Journal of Embryology and Experimental Morphology. 1966;16:381–390. - PubMed
    1. Afanasyev B. V., Elstner E. E., Zander A. R. A. J. Friedenstein, founder of the mesenchymal stem cell concept. Cellular Therapy and Transplantation. 2009;1(3):35–38. doi: 10.3205/ctt-2009-en-000029.01. - DOI
    1. Wong R. S. Mesenchymal stem cells: angels or demons? Journal of Biomedicine and Biotechnology. 2011;2011:8. doi: 10.1155/2011/459510.459510 - DOI - PMC - PubMed
    1. Tavassoli M., Crosby W. H. Transplantation of marrow to extramedullary sites. Science. 1968;161(3836):54–56. doi: 10.1126/science.161.3836.54. - DOI - PubMed
    1. Caplan A. I. Mesenchymal stem cells. Journal of Orthopaedic Research. 1991;9(5):641–650. doi: 10.1002/jor.1100090504. - DOI - PubMed